BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32705241)

  • 1. Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway.
    Wen L; Zhang X; Zhang J; Chen S; Ma Y; Hu J; Yue T; Wang J; Zhu J; Wu T; Wang X
    Oncol Rep; 2020 Sep; 44(3):1105-1115. PubMed ID: 32705241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paxillin is positively correlated with the clinicopathological factors of colorectal cancer, and knockdown of Paxillin improves sensitivity to cetuximab in colorectal cancer cells.
    Du C; Wang X; Zhang J; Liu X; Zhu J; Liu Y
    Oncol Rep; 2016 Jan; 35(1):409-17. PubMed ID: 26530439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSRP2 suppresses colorectal cancer progression
    Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
    Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.
    Chen DL; Wang DS; Wu WJ; Zeng ZL; Luo HY; Qiu MZ; Ren C; Zhang DS; Wang ZQ; Wang FH; Li YH; Kang TB; Xu RH
    Carcinogenesis; 2013 Apr; 34(4):803-11. PubMed ID: 23275153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Paxillin Expression and Phosphorylation on Colorectal Cancer Prognosis and Metastasis.
    Zheng H; Tsunedomi R; Xu M; Zhang Y; Kishi H; Kobayashi S; Tomochika S; Nakajima M; Matsui H; Tokumitsu Y; Shindo Y; Iida M; Ioka T; Nagano H
    Anticancer Res; 2024 Feb; 44(2):511-520. PubMed ID: 38307570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plastin 1 drives metastasis of colorectal cancer through the IQGAP1/Rac1/ERK pathway.
    Zhang T; Wang Z; Liu Y; Huo Y; Liu H; Xu C; Mao R; Zhu Y; Liu L; Wei D; Liu G; Pan B; Tang Y; Zhou Z; Yang C; Guo Y
    Cancer Sci; 2020 Aug; 111(8):2861-2871. PubMed ID: 32350953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAK, Src and p-Paxillin expression is decreased in liver metastasis of colorectal carcinoma patients.
    Mantonakis E; Giaginis C; Pikoulis E; Felekouras E; Patsouris E; Liakakos T; Papalampros E; Theocharis S
    J BUON; 2017; 22(5):1097-1106. PubMed ID: 29135089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression.
    Wu DW; Wu TC; Wu JY; Cheng YW; Chen YC; Lee MC; Chen CY; Lee H
    Oncogene; 2014 Aug; 33(35):4385-95. PubMed ID: 24096476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRPM7 deficiency suppresses cell proliferation, migration, and invasion in human colorectal cancer via regulation of epithelial-mesenchymal transition.
    Su F; Wang BF; Zhang T; Hou XM; Feng MH
    Cancer Biomark; 2019; 26(4):451-460. PubMed ID: 31640089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer.
    Ai X; Wu Y; Zhang W; Zhang Z; Jin G; Zhao J; Yu J; Lin Y; Zhang W; Liang H; Datta PK; Zhang M; Zhang B; Chen X
    Cancer Biol Ther; 2013 Nov; 14(11):1059-67. PubMed ID: 24025354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DUOX2 promotes the progression of colorectal cancer cells by regulating the AKT pathway and interacting with RPL3.
    Zhang X; Han J; Feng L; Zhi L; Jiang D; Yu B; Zhang Z; Gao B; Zhang C; Li M; Zhao L; Wang G
    Carcinogenesis; 2021 Feb; 42(1):105-117. PubMed ID: 32531052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
    Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
    Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spred2 inhibits epithelial‑mesenchymal transition of colorectal cancer cells by impairing ERK signaling.
    Wang H; Liu S; Kong F; Xiao F; Li Y; Wang H; Zhang S; Huang D; Wang L; Yang Y
    Oncol Rep; 2020 Jul; 44(1):174-184. PubMed ID: 32319644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
    Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
    Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
    [No Abstract]   [Full Text] [Related]  

  • 16. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
    Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
    J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic LIF reprograms invasive mode to enhance NPC dissemination through modulating YAP1-FAK/PXN signaling.
    Liu SC; Hsu T; Chang YS; Chung AK; Jiang SS; OuYang CN; Yuh CH; Hsueh C; Liu YP; Tsang NM
    Nat Commun; 2018 Nov; 9(1):5105. PubMed ID: 30504771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-mediated stabilization of Bcl-2 protein by phosphorylation at Serine 87.
    Huang CC; Wu DW; Lin PL; Lee H
    Oncotarget; 2015 Apr; 6(11):8698-708. PubMed ID: 25826088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.
    Qiang YY; Li CZ; Sun R; Zheng LS; Peng LX; Yang JP; Meng DF; Lang YH; Mei Y; Xie P; Xu L; Cao Y; Wei WW; Cao L; Hu H; Yang Q; Luo DH; Liang YY; Huang BJ; Qian CN
    J Exp Clin Cancer Res; 2018 Feb; 37(1):34. PubMed ID: 29463274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.